NORDWISE BioTech OÜ is a OÜ based in Tartu linn, registry code 14877534, status: active. Main activity: Research and experimental development on natural sciences and engineering. According to EMTA, turnover for Q3 2026 was €27 866 with 4 employees.
Turnover
27 866 €
↓ 47.7%vs Q2 2026
State taxes
6 056 €
↑ 1.7%vs Q2 2026
Labour taxes
6 484 €
↑ 7.5%vs Q2 2026
Employees
4
+1vs Q2 2026
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry Scientific research and development · EMTAK 72
Turnover · Q3 202627 866 €
above 65% of companies
industry median 14 442 € · companies in the industry: 318
Labour taxes per employee1 621 €
above 42% of companies
industry median 2 218 € · companies in the industry: 234
Revenue · 2025123 018 €
above 91% of companies
industry median 0 € · companies in the industry: 1 073
Net profit margin · 2025-88.6 %
above 9% of companies
industry median 13.5 % · companies in the industry: 597
Taxes and turnover
Q4 2023 – Q3 2026
Turnover, € Q3 2026: 27 866 € · −47.7% vs Q2 2026 · industry median 14 442 € · above 65% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Labour taxes per employee, € Q3 2026: 1 621 € · −19.4% vs Q2 2026 · industry median 2 218 € · above 42% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
EmployeesQ3 2026: 4 · +33.3% vs Q2 2026State taxes, € Q3 2026: 6 056 € · +1.7% vs Q2 2026
Figures by quarter
Quarter
Turnover, €
State taxes, €
Labour taxes, €
Employees
Q3 2026
27 866
6 056
6 484
4
Q2 2026
53 282
5 953
6 032
3
Q1 2026
49 461
6 829
6 041
3
Q4 2025
47 840
8 975
7 061
3
Q3 2025
22 695
7 527
6 421
3
Q2 2025
54 732
5 549
5 879
3
Q1 2025
19 935
5 727
5 240
3
Q4 2024
29 065
16 420
15 209
2
Q3 2024
61 128
7 817
7 460
2
Q2 2024
28 185
6 940
6 110
3
Q1 2024
53 489
6 139
4 757
3
Q4 2023
33 958
6 704
3 270
3
Q3 2023
19 368
6 535
4 098
3
Q2 2023
63 195
6 698
2 769
3
Q1 2023
32 703
5 503
2 527
2
Q4 2022
40 156
11 677
6 299
2
Q3 2022
28 601
10 564
7 523
3
Q2 2022
30 040
7 712
6 641
4
Q1 2022
76 375
12 855
6 594
4
Labour taxes per employee per month
540 €
Turnover per employee in the quarter
6 967 €
Q3 2026 · calculated from EMTA data
Financials by year
2020 – 2025
Revenue, € thousand 2025: 123 018 € · −11.6% vs 2024 · industry median 0 € · above 91% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Net profit, € thousand 2025: -109 012 € · +23.2% vs 2024 · industry median 0 € · above 2% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Net profit margin, % 2025: -88.6 % · +13.4 pp vs the year before · industry median 13.5 % · above 9% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Assets, € thousand 2025: 2 721 285 € · −2.4% vs 2024Equity, € thousand 2025: 2 481 254 € · −4.2% vs 2024Employees2025: 2 · +0.0% vs 2024 · industry median 1 · above 55% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Financials by year
Year
Revenue, €
Net profit, €
Labour costs, €
Assets, €
Equity, €
Employees
2025
123 018
-109 012
63 484
2 721 285
2 481 254
2
2024
139 175
-142 007
84 588
2 789 487
2 590 266
2
2023
127 238
-48 646
34 188
2 856 726
2 732 273
2
2022
163 938
-48 742
59 391
2 908 337
2 780 919
2
2021
148 201
-85 831
57 266
2 902 441
2 829 661
2
2020
53 822
-42 508
12 601
2 926 911
2 915 492
1
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2025
Net profit margin
-88.6 %
Net profit / revenue
Return on equity (ROE)
-4.4 %
Net profit / equity
Return on assets (ROA)
-4.0 %
Net profit / assets
Equity ratio
91.2 %
Equity / assets
Debt ratio
8.8 %
Liabilities / assets
Current ratio
0.54
Current assets / current liabilities
Revenue per employee
61 509 €
Revenue / average full-time employees
Labour cost per employee per month
2 645 €
Labour costs / employees / 12 months (incl. employer taxes)
